Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

KROSKROS
Showing 7 of 11 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in KEROS THERAPEUTICS INC

FEDERATED HERMES, INC. holds 700,427 shares of KROS (KEROS THERAPEUTICS INC), worth $7.5M as of 2026-Q2. The position was increased (+1.6% shares). KROS represents 0.0% of FEDERATED HERMES, INC.'s portfolio.

Current Value

$7.5M

Current Shares

700,427

Total Value Change

+$5.5M

Total Shares Change

+575,807

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
700,427
+1.6%
$7.5M0.0%$10.70
28
2026-Q1
Increased
689,229
+5.3%
$7.6M0.0%$13.40
29
2025-Q4
Increased
654,724
+27.3%
$13.3M0.0%$20.27
35
2025-Q3
Decreased
514,160
-21.4%
$8.1M0.0%$15.95
0
2025-Q2
Decreased
654,030
-46.6%
$8.7M0.0%$13.49
0
2025-Q1
Increased
1.2M
+882.3%
$12.5M0.0%$10.79
45
2024-Q4
New
124,620
-
$2M0.0%$15.64
36

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used